Search Results

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Ward-Decoration-Guidelines.docx

Christmas 2021 - IP&C guidance

DCHS Community Podiatry eligibility leaflet (2020).pdf

DCHS Community Podiatry eligibility leaflet (2020)

Community services visiting you at home _1.pdf

HRP29 Registration Re-Registration and Revalidation Manager's Guide.docx

Appendix 10: Blood bikes information

Appendix 10: Blood bikes information, for clinicians - Section 5.28 Covid 19 IP&C Policy

High Risk - Diabetes Foot Care information and advice leaflet.pub

DCHS Declaraton - Staff Other Reg Prof.pdf

DCHS_Respectful Resolution_Step 1 - Creating a safe culture

DAACSS Service Information